What is Your Opinion? Should We Have Price Controls When Drugs No Longer Reflect Their True Development Cost?
Traditionally, the FDA makes its regulatory decisions based solely on demonstrated safety and provable increases in meaningful survival data. The FDA asks, Will a new treatment that is being considered for approval be able to extend our life longer than the current standard of care? They also ask if it will extend our life is [...]